# CAR-T Cells Therapy for Patients With Autoimmune Diseases

> **NCT07052565** · NA · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis

## Key facts

- **NCT ID:** NCT07052565
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-20
- **Primary completion:** 2028-11-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07052565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07052565, "CAR-T Cells Therapy for Patients With Autoimmune Diseases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07052565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*